The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Quinn William P. since 2018.
This trader's CIK number is 1724190.
At the time of last reporting, Quinn William P. was the President, CEO and CFO of Bolt Biotherapeutics, Inc.. (stock ticker symbol BOLT).
Also see all insider trading activities at Bolt Biotherapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | BOLT | 5,000 | $2,834 | 0 | $0 | 0 | $0 |
2023 | BOLT | 11,829 | $11,241 | 0 | $0 | 0 | $0 |
2021 | BOLT | 7,456 | $68,066 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | SNSS | 12,000 | $6,072 | 0 | $0 | 0 | $0 |
2018 | SNSS | 40,000 | $18,800 | 0 | $0 | 0 | $0 |
1. Bolt Biotherapeutics, Inc. (BOLT)
2. Viracta Therapeutics, Inc. (SNSS)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-06-06 | BOLT | Buy | 2,500 | .64 | 1,592 |
2024-12-16 | BOLT | Buy | 2,500 | .50 | 1,242 |
2023-12-06 | BOLT | Buy | 2,500 | .78 | 1,955 |
2023-12-12 | BOLT | Buy | 7,500 | .95 | 7,125 |
2023-06-06 | BOLT | Buy | 1,829 | 1.18 | 2,161 |
2021-06-04 | BOLT | Buy | 1,221 | 16.65 | 20,329 |
2021-12-06 | BOLT | Buy | 35 | 4.64 | 162 |
2021-12-08 | BOLT | Buy | 5,000 | 4.71 | 23,575 |
2021-02-09 | BOLT | Buy | 1,200 | 20.00 | 24,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-11-29 | SNSS | Buy | 6,000 | .37 | 2,196 |
2019-05-31 | SNSS | Buy | 6,000 | .65 | 3,876 |
2018-12-10 | SNSS | Buy | 40,000 | .47 | 18,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Quinn William P. (President, CEO and CFO of Bolt Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.